All Stories

  1. Harnessing nature's blueprint: Unlocking the potential of subcellular structure membrane-coated nanosystems for precision medicine
  2. High drug-loaded supramolecular microgels enabled by controlled in-droplet self-assembly for adaptive treatment of inflammatory arthritis
  3. Combined M1 macrophage inhibition and thermotherapy for controlled fibroplasia and accelerated wound repair via an oxygenating ROS-responsive hydrogel
  4. Poly(lactic‐co‐glycolic acid) Nanoparticles for IL‐12 Self‐Amplifying RNA Delivery in Glioblastoma Models
  5. Identification of Subtype-Specific Vulnerabilities in Resistant Glioblastoma: A Computational Pipeline for Biomarkers and Drug Discovery
  6. Combating Gram-negative infections: The role of antimicrobial peptides and nanotechnology in overcoming antibiotic resistance
  7. A ratiometric theranostic nanoplatform with acid-triggered drug release and glutathione-activated fluorescence turn-on
  8. Design and in vitro validation of Brome mosaic –virus-like particles for gene delivery and immunomodulation of melanoma
  9. Quantum sensing of free radicals in macrophages reveals early autophagy-lysosome regulation in an atherosclerosis cell model
  10. Nanoencapsulated flavonoids for enhanced modulation of the microbiota-gut-brain axis and neurodegenerative add-on therapy
  11. Granular Hydrogels as Modular Biomaterials: From Structural Design to Biological Responses
  12. Outside Front Cover
  13. Programmable Nanostructure Assembly of a Paclitaxel Derivative Enables Tunable Anticancer Therapy via Hydrogen Bond Engineering
  14. Endocytic Programming via Porous Silicon Nanoparticles Enhances TLR4 Nanoagonist Potency for Macrophage‐Mediated Immunotherapy
  15. Wisdom of Crowds for Supporting the Safety Evaluation of Nanomaterials
  16. Organ-on-Chip Platforms for Nanoparticle Toxicity and Efficacy Assessment: Advancing Beyond Traditional In Vitro and In Vivo Models
  17. Metal-organic frameworks in sample preparation for clinical applications – A review
  18. Artificial cells and biomimicry cells: A rising star in the fight against cancer
  19. Probing Early Particle‐Cell Membrane Interactions via Single‐Cell and Single‐Particle Interaction Analysis
  20. Forging a New Frontier: Antimicrobial Peptides and Nanotechnology Converging to Conquer Gastrointestinal Pathogens
  21. Integrated Microfluidic Chip for Neutrophil Extracellular Vesicle Analysis and Gastric Cancer Diagnosis
  22. Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches
  23. Biological Augmentation Using Electrospun Constructs with Dual Growth Factor Release for Rotator Cuff Repair
  24. Identification of splenic IRF7 as a nanotherapy target for tele-conditioning myocardial reperfusion injury
  25. H2O2‐Generating Advanced Nanomaterials for Cancer Treatment
  26. Engineered Shape-Tunable Copper-Coordinated Nanoparticles for Macrophage Reprogramming
  27. Local glycolysis-modulating hydrogel microspheres for a combined anti-tumor and anti-metastasis strategy through metabolic trapping strategy
  28. Reactive oxygen species switcher via MnO2-coated Prussian blue loaded hyaluronic acid methacrylate hydrogel microspheres for local anti-tumor treatment
  29. Broad-spectrum downregulation of inflammatory cytokines by polydopamine nanoparticles to protect the injured spinal cord
  30. Amniotic epithelial Cell microvesicles uptake inhibits PBMCs and Jurkat cells activation by inducing mitochondria-dependent apoptosis
  31. Effects of LinTT1-peptide conjugation on the properties of poly(ethylene glycol)-block-(ε-caprolactone) nanoparticles prepared by the nanoprecipitation method
  32. Development of Amniotic Epithelial Stem Cells Secretome-Loaded In Situ Inverse Electron Demand Diels–Alder-Cross-Linked Hydrogel as a Potential Immunomodulatory Therapeutical Tool
  33. Hybrid lipid nanoparticles derived from human mesenchymal stem cell extracellular vesicles by microfluidic sonication for collagen I mRNA delivery to human tendon progenitor stem cells
  34. Engineering an oncolytic adenoviral platform for precise delivery of antisense peptide nucleic acid to modulate PD-L1 overexpression in cancer cells
  35. Hijacking plant skeletons for biomedical applications: from regenerative medicine and drug delivery to biosensing
  36. Hybrid Nanoparticles Dual‐Loaded With Curcumin and Benzydamine Hydrochloride for the Treatment of Vulvovaginal Candidiasis: From Development to Biological Application In Vitro and In Vivo (Adv. Therap. 1/2025)
  37. Tailored polysaccharide entrapping metal-organic framework for RNAi therapeutics and diagnostics in atherosclerosis
  38. Preface
  39. Technological Advances and Innovations in the Treatment of Chronic Respiratory Disorders
  40. A Near-Infrared Light Absorbable Hydrogel with Antibacterial Effect for Mild Photothermal Regeneration of Infected Wounds
  41. Polymeric Microspheres with High Mass Fraction of Therapeutics Enabled by the Manipulation of Kinetics Factor During Emulsion Droplet Solidification
  42. A study of the oral bioavailability and biodistribution increase of Nanoencapsulation-driven Delivering radiolabeled anthocyanins
  43. Fabrication of Biomimetic Hybrid Liposomes via Microfluidic Technology: Homotypic Targeting and Antitumor Efficacy Studies in Glioma Cells
  44. Interplay of nano-based delivery systems and protein signalling in ameliorating lung diseases
  45. Cyanocobalamin-loaded dissolving microneedles diminish skin inflammation in vivo
  46. Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model
  47. Electrochemical detection of atrial natriuretic peptide-coated nanocarriers based on a molecularly imprinted polymer receptor thin film
  48. Hybrid Nanoparticles Dual‐Loaded With Curcumin and Benzydamine Hydrochloride for the Treatment of Vulvovaginal Candidiasis: From Development to Biological Application In Vitro and In Vivo
  49. Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies
  50. A translational framework to DELIVER nanomedicines to the clinic
  51. Breaking barriers: The potential of nanosystems in antituberculosis therapy
  52. Next-generation chemotherapy treatments based on black hole algorithms: From cancer remission to chronic disease management
  53. Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer
  54. Quantitative analysis of electroporation-mediated intracellular delivery via bioorthogonal luminescent reaction
  55. Unlocking the potential of nanomedicine: advances in precision targeting strategies
  56. Front Cover: Nano Select 7–8 / 2024
  57. Self‐Nanoformulating Poly(2‐oxazoline) and Poly(2‐oxazine) Copolymers Based Amorphous Solid Dispersions as Microneedle Patch: A Formulation Study
  58. Antifibrotic and Pro-regenerative Effects of SMAD3 siRNA and Collagen I mRNA-Loaded Lipid Nanoparticles in Human Tenocytes
  59. Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges
  60. Special Issue on Advances in Porous Materials
  61. Comparative optimization of polysaccharide-based nanoformulations for cardiac RNAi therapy
  62. Implantable Patch of Oxidized Nanofibrillated Cellulose and Lysozyme Amyloid Nanofibrils for the Regeneration of Infarcted Myocardium Tissue and Local Delivery of RNA‐Loaded Nanoparticles
  63. Lipid nanoparticles-based RNA therapies for breast cancer treatment
  64. Self-Nanoformulating Poly(2-oxazoline) and Poly(2-oxazine) Copolymers Based Amorphous Solid Dispersions as Microneedle Patch: A Formulation Study
  65. Curcuma Longa: Nutraceutical Use and Association With Nanotechnology
  66. Advances in Microfluidic‐Based Core@Shell Nanoparticles Fabrication for Cancer Applications
  67. Revolutionizing lung health: Exploring the latest breakthroughs and future prospects of synbiotic nanostructures in lung diseases
  68. Study of the Synergistic Immunomodulatory and Antifibrotic Effects of Dual-Loaded Budesonide and Serpine1 siRNA Lipid–Polymer Nanoparticles Targeting Macrophage Dysregulation in Tendinopathy
  69. In Situ Biofabrication of Microbial Cellulose Capsules Carrying Cubosomes: Toward Colon Targeted Multidrug Delivery
  70. Biomimetic Platelet‐Cloaked Nanoparticles for the Delivery of Anti‐Inflammatory Curcumin in the Treatment of Atherosclerosis
  71. Physicochemical characterization of a lycopene‐loaded mesoporous silica nanoparticle formulation
  72. Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: Development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model
  73. Host-Directed Virus-Mimicking Particles Interacting with the ACE2 Receptor Competitively Block Coronavirus SARS-CoV-2 Entry
  74. New insights into nanomedicines for oral delivery of glucagon‐like peptide‐1 analogs
  75. Engineering and Targeting Neutrophils for Cancer Therapy
  76. Porous Silicon Nanoparticles Conjugated Magnetite‐Chitosan Graphene Oxide Nanoparticles for Effective Removal of Complex Pollutants
  77. Inside Back Cover
  78. Diatom-guided bone healing via a hybrid natural scaffold
  79. Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular trafficking of semaglutide
  80. Quantum Sensing of Free Radical Generation in Mitochondria of Single Heart Muscle Cells during Hypoxia and Reoxygenation
  81. Porous Si-Based Nanosystems for Immunotherapy Applications
  82. Noninvasive Novel Transdermal Drug Delivery System for Deep Drug Permeability
  83. Cell-based in vitro models for buccal permeability studies
  84. Manganese@Albumin Nanocomplex and Its Assembled Nanowire Activate TLR4‐Dependent Signaling Cascades of Macrophages
  85. Diversity-oriented combinatory formulation screen for cardiac RNAi therapeutics with polysaccharide framework
  86. Polyethylene Glycol‐Stabilized Gold Nanostars‐Loaded Microneedles for Photothermal Therapy of Melanoma
  87. Enhancing Apoptosome Assembly via Mito‐Biomimetic Lipid Nanocarrier for Cancer Therapy (Adv. Funct. Mater. 46/2023)
  88. Emerging applications and prospects of NFκB decoy oligodeoxynucleotides in managing respiratory diseases
  89. Advanced porous materials for antimicrobial treatment
  90. Evaluation of cell membrane-derived nanoparticles as therapeutic carriers for pancreatic ductal adenocarcinoma using an in vitro tumour stroma model
  91. Mycophenolic Acid-loaded Naïve Macrophage-derived Extracellular Vesicles Rescue Cardiac Myoblast after Inflammatory Injury
  92. Acid-labile chemical bonds-based nanoparticles for endosome escape and intracellular delivery
  93. Recent advances in Fenton and Fenton-like reaction mediated nanoparticle in cancer therapy
  94. Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond
  95. Development of a time-dependent oral colon delivery system of anaerobic Odoribacter splanchnicus for bacteriotherapy
  96. Macrophage Hitchhiking Nanoparticles for the Treatment of Myocardial Infarction: An In Vitro and In Vivo Study (Adv. Funct. Mater. 34/2023)
  97. Enhancing Apoptosome Assembly via Mito‐Biomimetic Lipid Nanocarrier for Cancer Therapy
  98. Cancer Models on Chip: Paving the Way to Large‐Scale Trial Applications
  99. Development of fast dissolving polymer-based microneedles for delivery of an antigenic melanoma cell membrane
  100. Double‐Layered Polyvinylpyrrolidone–Poly(methyl vinyl ether‐alt‐maleic acid)‐Based Microneedles to Deliver Meloxicam: An In Vitro, In Vivo, and Short‐Term Stability Evaluation Study
  101. In Vitro Characterization and Real-Time Label-Free Assessment of the Interaction of Chitosan-Coated Niosomes with Intestinal Cellular Monolayers
  102. Fabricated technology of biomedical micro-nano hydrogel
  103. Multifunctional nanostructures: Intelligent design to overcome biological barriers
  104. Development of siRNA and Budesonide Dual‐Loaded Hybrid Lipid–Polymer Nanoparticles by Microfluidics Technology as a Platform for Dual Drug Delivery to Macrophages: An In Vitro Mechanistic Study
  105. Macrophage Hitchhiking Nanoparticles for the Treatment of Myocardial Infarction: An In Vitro and In Vivo Study
  106. Injectable Nanocomposite Hydrogels of Gelatin-Hyaluronic Acid Reinforced with Hybrid Lysozyme Nanofibrils-Gold Nanoparticles for the Regeneration of Damaged Myocardium
  107. In Vitro Study of the Anti-inflammatory and Antifibrotic Activity of Tannic Acid-Coated Curcumin-Loaded Nanoparticles in Human Tenocytes
  108. Nanoparticles-based phototherapy systems for cancer treatment: Current status and clinical potential
  109. Rational design of a polysaccharide-based viral mimicry nanocomplex for potent gene silencing in inflammatory tissues
  110. Controlled Interfacial Polymer Self‐Assembly Coordinates Ultrahigh Drug Loading and Zero‐Order Release in Particles Prepared under Continuous Flow
  111. A photoactive injectable antibacterial hydrogel to support chemo-immunotherapeutic effect of antigenic cell membrane and sorafenib by near-infrared light mediated tumor ablation
  112. Microfluidic preparation and optimization of sorafenib-loaded poly(ethylene glycol-block-caprolactone) nanoparticles for cancer therapy applications
  113. Nanostructured multifunctional stimuli-responsive glycopolypeptide-based copolymers for biomedical applications
  114. Porous Silicon Nanocarriers Boost the Immunomodulation of Mitochondria-Targeted Bovine Serum Albumins on Macrophage Polarization
  115. Recent approaches for enhancing the performance of dissolving microneedles in drug delivery applications
  116. Introduction to the RSC Advances themed collection on Nanomaterials in drug delivery
  117. Microfluidic‐Assisted Production of Gastro‐Resistant Active‐Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells (Adv. Healthcare Mater. 6/2023)
  118. Microfluidics as a Tool for the Synthesis of Advanced Drug Delivery Systems
  119. Fabrication of hydrogel microspheres via microfluidics using inverse electron demand Diels–Alder click chemistry-based tetrazine-norbornene for drug delivery and cell encapsulation applications
  120. Smart Nanoparticle‐based Platforms for Regulating Tumor Microenvironment and Cancer Immunotherapy
  121. Microfluidic‐Assisted Production of Gastro‐Resistant Active‐Targeted Diatomite Nanoparticles for the Local Release of Galunisertib in Metastatic Colorectal Cancer Cells
  122. A pH‐Responsive Cluster Metal–Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect (Adv. Mater. 42/2022)
  123. A pH‐Responsive Cluster Metal–Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect
  124. Development of Surface Chemical Strategies for Synthesizing Redox‐Responsive Diatomite Nanoparticles as a Green Platform for On‐Demand Intracellular Release of an Antisense Peptide Nucleic Acid Anticancer Agent
  125. Promoting Cardiac Repair through Simple Engineering of Nanoparticles with Exclusive Targeting Capability toward Myocardial Reperfusion Injury by Thermal Resistant Microfluidic Platform (Adv. Funct. Mater. 36/2022)
  126. Folic acid-mesoporous silicon nanoparticles enhance the anticancer activity of the p73-activating small molecule LEM2
  127. Promoting Cardiac Repair through Simple Engineering of Nanoparticles with Exclusive Targeting Capability toward Myocardial Reperfusion Injury by Thermal Resistant Microfluidic Platform
  128. Microfluidics fabrication of micrometer‐sized hydrogels with precisely controlled geometries for biomedical applications
  129. Current trends in delivery of non-viral nucleic acid-based therapeutics for improved efficacy
  130. Autologous Skin Fibroblast‐Based PLGA Nanoparticles for Treating Multiorgan Fibrosis
  131. Molecular scale study on the interactions of biocompatible nanoparticles with macrophage membrane and blood proteins
  132. Mussel-Inspired and Bioclickable Peptide Engineered Surface to Combat Thrombosis and Infection
  133. Inhaled hydrogel-based microspheres for management of COVID-19: A new sweeper biological platform
  134. Progress in Stimuli‐Responsive Biomaterials for Treating Cardiovascular and Cerebrovascular Diseases
  135. Artificial Intelligence Deep Exploration of Influential Parameters on Physicochemical Properties of Curcumin‐Loaded Electrospun Nanofibers
  136. High drug-loaded microspheres enabled by controlled in-droplet precipitation promote functional recovery after spinal cord injury
  137. Functional biomaterials
  138. Neonatal Fc receptor-targeted lignin-encapsulated porous silicon nanoparticles for enhanced cellular interactions and insulin permeation across the intestinal epithelium
  139. Biomimetic platelet membrane-coated nanoparticles for targeted therapy
  140. Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak‐Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors (Adv. Mater. 9/2022)
  141. Surface Adsorption‐Mediated Ultrahigh Efficient Peptide Encapsulation with a Precise Ratiometric Control for Type 1 and 2 Diabetic Therapy
  142. Gelatin‐Lysozyme Nanofibrils Electrospun Patches with Improved Mechanical, Antioxidant and Bioresorbability Properties for Myocardial Regeneration Applications
  143. Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak‐Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors
  144. Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy
  145. Scaffold Vaccines for Generating Robust and Tunable Antibody Responses
  146. Synergistic immunomodulatory effect in macrophages mediated by magnetic nanoparticles modified with miRNAs
  147. Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells
  148. Emerging Theranostic Nanomaterials in Diabetes and Its Complications
  149. Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds
  150. Inhibiting Phase Transfer of Protein Nanoparticles by Surface Camouflage–A Versatile and Efficient Protein Encapsulation Strategy
  151. In Vitro Evaluation of the Therapeutic Effects of Dual‐Drug Loaded Spermine‐Acetalated Dextran Nanoparticles Coated with Tannic Acid for Cardiac Applications
  152. Prospective Cancer Therapies Using Stimuli‐Responsive DNA Nanostructures
  153. Dual‐Crosslinked Dynamic Hydrogel Incorporating {Mo 154 } with pH and NIR Responsiveness for Chemo‐Photothermal Therapy (Adv. Mater. 40/2021)
  154. Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy
  155. Programmable immune activating electrospun fibers for skin regeneration
  156. Nonresonant CARS Imaging of Porous and Solid Silicon Nanoparticles in Human Cells
  157. Engineering of 2D nanomaterials to trap and kill SARS-CoV-2: a new insight from multi-microsecond atomistic simulations
  158. Dual‐Crosslinked Dynamic Hydrogel Incorporating {Mo 154 } with pH and NIR Responsiveness for Chemo‐Photothermal Therapy
  159. Prevention of diabetes-associated fibrosis: Strategies in FcRn-targeted nanosystems for oral drug delivery
  160. Quantitative Analysis of Porous Silicon Nanoparticles Functionalization by 1H NMR
  161. Engineering of 2D Materials To Trap And Kill SARS-CoV-2: A New Insight From Multi-Microsecond Atomistic Simulations
  162. Light‐Controlled Nanosystems: Light‐Controlled Nanosystem with Size‐Flexibility Improves Targeted Retention for Tumor Suppression (Adv. Funct. Mater. 27/2021)
  163. Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines
  164. Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics
  165. Multistage signal-interactive nanoparticles improve tumor targeting through efficient nanoparticle-cell communications
  166. An organic-inorganic hybrid scaffold with honeycomb-like structures enabled by one-step self-assembly-driven electrospinning
  167. Light‐Controlled Nanosystem with Size‐Flexibility Improves Targeted Retention for Tumor Suppression
  168. A Theranostic Cellulose Nanocrystal‐Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma
  169. Mitochondria‐Targeted Bovine Serum Albumin@Copper Sulfide Nanocomposites Conjugated with Rhodamine‐110 Dye for an Enhanced Efficacy of Cancer Photothermal Therapy
  170. Chemically Engineered Immune Cell‐Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools
  171. DNA‐Grafted Hyaluronic Acid System with Enhanced Injectability and Biostability for Photo‐Controlled Osteoarthritis Gene Therapy
  172. LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy
  173. Synthesis and therapeutic potential of stimuli-responsive metal-organic frameworks
  174. One-step microfluidics production of enzyme-loaded liposomes for the treatment of inflammatory diseases
  175. Engineered Extracellular Vesicles for Cancer Therapy
  176. Development of vaccine formulations: past, present, and future
  177. Nanoparticle‐mediated siRNA delivery systems for cancer therapy
  178. Microneedles for painless transdermal immunotherapeutic applications
  179. Anti‐Bacterial Hydrogels: A Hydrogen‐Bonded Extracellular Matrix‐Mimicking Bactericidal Hydrogel with Radical Scavenging and Hemostatic Function for pH‐Responsive Wound Healing Acceleration (Adv. Healthcare Mater. 3/2021)
  180. Intraoperative Assessment and Photothermal Ablation of the Tumor Margins Using Gold Nanoparticles
  181. Correction: Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications
  182. Front cover
  183. Advanced Nanosystems for Clinical Translation
  184. Investigation of silicon nanoparticles produced by centrifuge chemical vapor deposition for applications in therapy and diagnostics
  185. Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications
  186. Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds
  187. Conventional Nanosized Drug Delivery Systems for Cancer Applications
  188. Front Matter
  189. Introduction to lignocellulosic materials
  190. Requirements and properties of biomaterials for biomedical applications
  191. Bio-Nanomedicine for Cancer Therapy
  192. Porous Silicon for Biomedical Applications
  193. Combination Therapy of Killing Diseases by Injectable Hydrogels: From Concept to Medical Applications
  194. Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique
  195. Evaluation of the effects of nanoprecipitation process parameters on the size and morphology of poly(ethylene oxide)-block-polycaprolactone nanostructures
  196. Recent progress in the design of DNA vaccines against tuberculosis
  197. Cell–Nanoparticle Interactions: Toxicity and Safety Issues
  198. A Hydrogen‐Bonded Extracellular Matrix‐Mimicking Bactericidal Hydrogel with Radical Scavenging and Hemostatic Function for pH‐Responsive Wound Healing Acceleration
  199. One‐Pot Synthesis of pH‐Responsive Eudragit‐Mesoporous Silica Nanocomposites Enable Colonic Delivery of Glucocorticoids for the Treatment of Inflammatory Bowel Disease
  200. Requirements for Animal Experiments: Problems and Challenges
  201. Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines
  202. 3D scaffolding of fast photocurable polyurethane for soft tissue engineering by stereolithography: Influence of materials and geometry on growth of fibroblast cells
  203. Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines
  204. Cell Membrane Wrapping: Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions (Adv. Healthcare Mater. 17/2020)
  205. Formulation optimization and in vitro characterization of rifampicin and ceftriaxone dual drug loaded niosomes with high energy probe sonication technique
  206. Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions
  207. Colorectal cancer triple co-culture spheroid model to assess the biocompatibility and anticancer properties of polymeric nanoparticles
  208. Multifunctional 3D‐Printed Patches for Long‐Term Drug Release Therapies after Myocardial Infarction
  209. Tandem‐Mass‐Tag Based Proteomic Analysis Facilitates Analyzing Critical Factors of Porous Silicon Nanoparticles in Determining Their Biological Responses under Diseased Condition
  210. Intracellular Delivery of Budesonide and Polydopamine Co‐Loaded in Endosomolytic Poly(butyl methacrylate‐ co ‐methacrylic acid) Grafted Acetalated Dextran for Macrophage Phenotype Switch from M1 to M2
  211. The Progress and Prospect of Zeolitic Imidazolate Frameworks in Cancer Therapy, Antibacterial Activity, and Biomineralization
  212. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery
  213. Microvascular Scaffolds: A Biomimetic 3D‐Self‐Forming Approach for Microvascular Scaffolds (Adv. Sci. 9/2020)
  214. Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with 155Tb
  215. Polyoxometalate Composites in Cancer Therapy and Diagnostics
  216. The solid progress of nanomedicine
  217. A Biomimetic 3D‐Self‐Forming Approach for Microvascular Scaffolds
  218. Microfluidics: Microfluidics for Production of Particles: Mechanism, Methodology, and Applications (Small 9/2020)
  219. Gold–silver nanoshells promote wound healing from drug-resistant bacteria infection and enable monitoring via surface-enhanced Raman scattering imaging
  220. Recent trends on the development of systems for cancer diagnosis and treatment by microfluidic technology
  221. Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach
  222. Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
  223. Advanced liposome-loaded scaffolds for therapeutic and tissue engineering applications
  224. Fabrication and Characterization of Drug-Loaded Conductive Poly(glycerol sebacate)/Nanoparticle-Based Composite Patch for Myocardial Infarction Applications
  225. Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applications
  226. Near-infrared light and magnetic field dual-responsive porous silicon-based nanocarriers to overcome multidrug resistance in breast cancer cells with enhanced efficiency
  227. Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke
  228. Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction
  229. The versatile biomedical applications of bismuth-based nanoparticles and composites: therapeutic, diagnostic, biosensing, and regenerative properties
  230. Microfibers synthesized by wet-spinning of chitin nanomaterials: mechanical, structural and cell proliferation properties
  231. New insights into ethionamide metabolism: influence of oxidized methionine on its degradation path
  232. Hybrid red blood cell membrane coated porous silicon nanoparticles functionalized with cancer antigen induce depletion of T cells
  233. Novel RET agonist for the treatment of experimental neuropathies
  234. Oral drug delivery: Overview
  235. Spray-drying for the formulation of oral drug delivery systems
  236. All-in-one microfluidic assembly of insulin-loaded pH-responsive nano-in-microparticles for oral insulin delivery
  237. Mild temperature photothermal assisted anti-bacterial and anti-inflammatory nanosystem for synergistic treatment of post-cataract surgery endophthalmitis
  238. Superfast and controllable microfluidic inking of anti-inflammatory melanin-like nanoparticles inspired by cephalopods
  239. Gene‐Hydrogel Microenvironments: Gene‐Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus (Adv. Sci. 1/2020)
  240. Osteogenic Hydrogels: Gelatin Templated Polypeptide Co‐Cross‐Linked Hydrogel for Bone Regeneration (Adv. Healthcare Mater. 1/2020)
  241. Cover Image
  242. Nanotechnology for Oral Drug Delivery
  243. Nanomedicine Therapies
  244. Handbook of In Vivo Chemistry in Mice
  245. Systematic in vitro biocompatibility studies of multimodal cellulose nanocrystal and lignin nanoparticles
  246. Gelatin Templated Polypeptide Co‐Cross‐Linked Hydrogel for Bone Regeneration
  247. Artificially cloaked viral nanovaccine for cancer immunotherapy
  248. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes
  249. Antitumor Therapeutics: A Virus‐Mimicking pH‐Responsive Acetalated Dextran‐Based Membrane‐Active Polymeric Nanoparticle for Intracellular Delivery of Antitumor Therapeutics (Adv. Funct. Mater. 51/2019)
  250. Functionalized Bacterial Cellulose Microparticles for Drug Delivery in Biomedical Applications
  251. Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targeting
  252. Microfluidics for Production of Particles: Mechanism, Methodology, and Applications
  253. Gene‐Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus
  254. A Virus‐Mimicking pH‐Responsive Acetalated Dextran‐Based Membrane‐Active Polymeric Nanoparticle for Intracellular Delivery of Antitumor Therapeutics
  255. Latest Advances on Bacterial Cellulose‐Based Materials for Wound Healing, Delivery Systems, and Tissue Engineering
  256. Landing a lethal blow on bacterial infections: an emerging advance of nanodots for wound healing acceleration
  257. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
  258. Antimicrobial Colloidal Silver–Lignin Particles via Ion and Solvent Exchange
  259. Metal Species–Encapsulated Mesoporous Silica Nanoparticles: Current Advancements and Latest Breakthroughs
  260. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine
  261. Publisher Correction: On the issue of transparency and reproducibility in nanomedicine
  262. Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
  263. On the issue of transparency and reproducibility in nanomedicine
  264. Self-Healing and Injectable Hydrogel for Matching Skin Flap Regeneration
  265. Acetalated Dextran Nanoparticles Loaded into an Injectable Alginate Cryogel for Combined Chemotherapy and Cancer Vaccination
  266. Microfluidics: Nuts and Bolts: Microfluidics for the Production of Biomaterials (Adv. Mater. Technol. 6/2019)
  267. Acetylated Nanocellulose for Single-Component Bioinks and Cell Proliferation on 3D-Printed Scaffolds
  268. Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor
  269. Preparation and Characterization of Dentin Phosphophoryn‐Derived Peptide‐Functionalized Lignin Nanoparticles for Enhanced Cellular Uptake
  270. Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy
  271. Automatic methodologies to perform loading and release assays of anticancer drugs from mesoporous silicon nanoparticles
  272. Process optimization of ecological probe sonication technique for production of rifampicin loaded niosomes
  273. Photothermal-responsive nanosized hybrid polymersome as versatile therapeutics codelivery nanovehicle for effective tumor suppression
  274. Correction to “Targeted Reinforcement of Macrophage Reprogramming Toward M2 Polarization by IL-4-Loaded Hyaluronic Acid Particles”
  275. Porous Silicon as a Platform for Radiation Theranostics Together with a Novel RIB-Based Radiolanthanoid
  276. Self‐Healing: Self‐Healing and Injectable Hydrogel for Matching Skin Flap Regeneration (Adv. Sci. 3/2019)
  277. Metal-Based Stents: Endovascular Metal Devices for the Treatment of Cerebrovascular Diseases (Adv. Mater. 8/2019)
  278. Nuts and Bolts: Microfluidics for the Production of Biomaterials
  279. Laser-Activatable CuS Nanodots to Treat Multidrug-Resistant Bacteria and Release Copper Ion to Accelerate Healing of Infected Chronic Nonhealing Wounds
  280. Outer–inner dual reinforced micro/nano hierarchical scaffolds for promoting osteogenesis
  281. Advanced Nanovaccines for Immunotherapy Applications: From Concept to Animal Tests
  282. Close-loop dynamic nanohybrids on collagen-ark with in situ gelling transformation capability for biomimetic stage-specific diabetic wound healing
  283. Microfluidic mixing and devices for preparing nanoparticulate drug delivery systems
  284. Photosensitive materials for constructing on-demanded drug-release systems
  285. Targeted Reinforcement of Macrophage Reprogramming Toward M2 Polarization by IL-4-Loaded Hyaluronic Acid Particles
  286. Endovascular Metal Devices for the Treatment of Cerebrovascular Diseases
  287. Microfluidic Nanoassembly of Bioengineered Chitosan-Modified FcRn-Targeted Porous Silicon Nanoparticles @ Hypromellose Acetate Succinate for Oral Delivery of Antidiabetic Peptides
  288. Euryale Ferox Seed-Inspired Superlubricated Nanoparticles for Treatment of Osteoarthritis
  289. Adjustable hardness of hydrogel for promoting vascularization and maintaining stemness of stem cells in skin flap regeneration
  290. Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine
  291. Cellular Internalization-Induced Aggregation of Porous Silicon Nanoparticles for Ultrasound Imaging and Protein-Mediated Protection of Stem Cells
  292. Electrospun Fibrous Architectures for Drug Delivery, Tissue Engineering and Cancer Therapy
  293. Cell‐Nanoparticle Interactions at (Sub)–Nanometer Resolution Analyzed by Electron Microscopy and Correlative Coherent Anti‐Stokes Raman Scattering
  294. Self‐Healing and Injectable Hydrogel for Matching Skin Flap Regeneration
  295. Radiolabeled Molecular Imaging Probes for the In Vivo Evaluation of Cellulose Nanocrystals for Biomedical Applications
  296. pH and Reactive Oxygen Species‐Sequential Responsive Nano‐in‐Micro Composite for Targeted Therapy of Inflammatory Bowel Disease
  297. Localized Controlled Delivery of Gemcitabine via Microsol Electrospun Fibers to Prevent Pancreatic Cancer Recurrence
  298. GDNF mimetics delivery by porous silicon nanoparticles for improved Parkinson’s disease management
  299. DNA Hydrogel Assemblies: Bridging Synthesis Principles to Biomedical Applications
  300. Light-Activatable Assembled Nanoparticles to Improve Tumor Penetration and Eradicate Metastasis in Triple Negative Breast Cancer
  301. Impact of Pore Size and Surface Chemistry of Porous Silicon Particles and Structure of Phospholipids on Their Interactions
  302. Materials Science in Finland
  303. Production of pure drug nanocrystals and nano co-crystals by confinement methods
  304. Materials Science in Finland: (Adv. Mater. 24/2018)
  305. Engineered Multifunctional Albumin-Decorated Porous Silicon Nanoparticles for FcRn Translocation of Insulin
  306. Mesoporous Silica Nanoparticles for Targeted and Stimuli-Responsive Delivery of Chemotherapeutics: A Review
  307. Sequential Antifouling Surface for Efficient Modulation of the Nanoparticle-Cell Interactions in Protein-Rich Environments
  308. Bioengineered Porous Silicon Nanoparticles@Macrophages Cell Membrane as Composite Platforms for Rheumatoid Arthritis
  309. Electrospun Polyhydroxybutyrate/Poly(ε-caprolactone)/Sol–Gel-Derived Silica Hybrid Scaffolds with Drug Releasing Function for Bone Tissue Engineering Applications
  310. Properties and chemical modifications of lignin: Towards lignin-based nanomaterials for biomedical applications
  311. Neuroprotection: Biodegradable Spheres Protect Traumatically Injured Spinal Cord by Alleviating the Glutamate-Induced Excitotoxicity (Adv. Mater. 14/2018)
  312. Immunostimulation and Immunosuppression: Nanotechnology on the Brink
  313. Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4–NKX2-5 Interaction
  314. Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy
  315. The importance of microfluidics for the preparation of nanoparticles as advanced drug delivery systems
  316. Current developments and applications of microfluidic technology toward clinical translation of nanomedicines
  317. Cell Membrane-Based Nanoreactor To Mimic the Bio-Compartmentalization Strategy of a Cell
  318. Biodegradable Spheres Protect Traumatically Injured Spinal Cord by Alleviating the Glutamate-Induced Excitotoxicity
  319. Gold Nanorods Conjugated Porous Silicon Nanoparticles Encapsulated in Calcium Alginate Nano Hydrogels Using Microemulsion Templates
  320. Dual-Drug Delivery Using Dextran-Functionalized Nanoparticles Targeting Cardiac Fibroblasts for Cellular Reprogramming
  321. An immunological electrospun scaffold for tumor cell killing and healthy tissue regeneration
  322. Biofunctionalized Mesoporous Silica Nanomaterials for Targeted Drug Delivery
  323. Conductive vancomycin-loaded mesoporous silica polypyrrole-based scaffolds for bone regeneration
  324. The Emerging Role of Multifunctional Theranostic Materials in Cancer Nanomedicine
  325. 3D printing: prospects and challenges
  326. Functionalization of carboxylated lignin nanoparticles for targeted and pH-responsive delivery of anticancer drugs
  327. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications
  328. Cancer Therapy: Nutlin‐3a and Cytokine Co‐loaded Spermine‐Modified Acetalated Dextran Nanoparticles for Cancer Chemo‐Immunotherapy (Adv. Funct. Mater. 42/2017)
  329. Manipulating Superparamagnetic Microparticles with an Electromagnetic Needle
  330. Multifunctional Nanohybrid Based on Porous Silicon Nanoparticles, Gold Nanoparticles, and Acetalated Dextran for Liver Regeneration and Acute Liver Failure Theranostics
  331. Fabrication of Calcium Phosphate-Based Nanocomposites Incorporating DNA Origami, Gold Nanorods, and Anticancer Drugs for Biomedical Applications
  332. Nutlin-3a and Cytokine Co-loaded Spermine-Modified Acetalated Dextran Nanoparticles for Cancer Chemo-Immunotherapy
  333. Non-invasive strategies for targeting the posterior segment of eye
  334. Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals
  335. Protein Coating of DNA Nanostructures for Enhanced Stability and Immunocompatibility
  336. Drug-Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling
  337. Multifunctional Nanotube-Mucoadhesive Poly(methyl vinyl ether-co -maleic acid)@Hydroxypropyl Methylcellulose Acetate Succinate Composite for Site-Specific Oral Drug Delivery
  338. Photoluminescent Hybrids of Cellulose Nanocrystals and Carbon Quantum Dots as Cytocompatible Probes for in Vitro Bioimaging
  339. Coating Nanoparticles with Plant-Produced Transferrin–Hydrophobin Fusion Protein Enhances Their Uptake in Cancer Cells
  340. A multifunctional nanocomplex for enhanced cell uptake, endosomal escape and improved cancer therapeutic effect
  341. Surface modification of acetaminophen particles by atomic layer deposition
  342. The impact of porous silicon nanoparticles on human cytochrome P450 metabolism in human liver microsomes in vitro
  343. Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines
  344. Insights into Caco-2 cell culture structure using coherent anti-Stokes Raman scattering (CARS) microscopy
  345. A Versatile Carbonic Anhydrase IX Targeting Ligand-Functionalized Porous Silicon Nanoplatform for Dual Hypoxia Cancer Therapy and Imaging
  346. Microfluidic Encapsulation of Prickly Zinc-Doped Copper Oxide Nanoparticles with VD1142 Modified Spermine Acetalated Dextran for Efficient Cancer Therapy
  347. Receptor-Mediated Surface Charge Inversion Platform Based on Porous Silicon Nanoparticles for Efficient Cancer Cell Recognition and Combination Therapy
  348. Intracellular responsive dual delivery by endosomolytic polyplexes carrying DNA anchored porous silicon nanoparticles
  349. Nanoreactors: Biomimetic Engineering Using Cancer Cell Membranes for Designing Compartmentalized Nanoreactors with Organelle-Like Functions (Adv. Mater. 11/2017)
  350. Drug Delivery: A Nano-in-Nano Vector: Merging the Best of Polymeric Nanoparticles and Drug Nanocrystals (Adv. Funct. Mater. 9/2017)
  351. In vitro evaluation of biodegradable lignin-based nanoparticles for drug delivery and enhanced antiproliferation effect in cancer cells
  352. Preparation and biological evaluation of ethionamide-mesoporous silicon nanoparticles against Mycobacterium tuberculosis
  353. Nanovaccines: Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy (Adv. Mater. 7/2017)
  354. Fabrication, characterization and evaluation of bacterial cellulose-based capsule shells for oral drug delivery
  355. Biomimetic Engineering Using Cancer Cell Membranes for Designing Compartmentalized Nanoreactors with Organelle-Like Functions
  356. A Nano-in-Nano Vector: Merging the Best of Polymeric Nanoparticles and Drug Nanocrystals
  357. Core/Shell Nanocomposites Produced by Superfast Sequential Microfluidic Nanoprecipitation
  358. Cell Scaffolds: Electrospun Photocrosslinkable Hydrogel Fibrous Scaffolds for Rapid In Vivo Vascularized Skin Flap Regeneration (Adv. Funct. Mater. 2/2017)
  359. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy
  360. Microfluidic-assisted fabrication of carriers for controlled drug delivery
  361. Microfluidics platform for glass capillaries and its application in droplet and nanoparticle fabrication
  362. Springer Handbook of Nanotechnology
  363. Nano-Particles for Biomedical Applications
  364. Inside Cover Image, Volume 9, Issue 1
  365. Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy
  366. Quercetin-Based Modified Porous Silicon Nanoparticles for Enhanced Inhibition of Doxorubicin-Resistant Cancer Cells
  367. Drug Delivery: Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle-functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy (Adv. Mater. 46/2016)
  368. Microparticles to enhance delivery of drugs and growth factors into wound sites
  369. Active diffusion of nanoparticles of maternal origin within the embryonic brain
  370. Advances in biomedical and pharmaceutical applications of functional bacterial cellulose-based nanocomposites
  371. Gold Nanorods, DNA Origami, and Porous Silicon Nanoparticle‐functionalized Biocompatible Double Emulsion for Versatile Targeted Therapeutics and Antibody Combination Therapy
  372. Enhanced Photoluminescence in Acetylene-Treated ZnO Nanorods
  373. Angiopep2-functionalized polymersomes for targeted doxorubicin delivery to glioblastoma cells
  374. Microfluidics as a cutting-edge technique for drug delivery applications
  375. Targeted Cancer Therapy: pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin (Adv. Healthcare Mater. 15/2016)
  376. Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?
  377. Antiproliferative Activity and Cellular Uptake of Evodiamine and Rutaecarpine Based on 3D Tumor Models
  378. In vitro and in vivo assessment of heart-homing porous silicon nanoparticles
  379. Silica-Based Nanovectors: From Mother Nature to Biomedical Applications
  380. Applications of bacterial cellulose in food, cosmetics and drug delivery
  381. pH-Switch Nanoprecipitation of Polymeric Nanoparticles for Multimodal Cancer Targeting and Intracellular Triggered Delivery of Doxorubicin
  382. Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model
  383. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin
  384. A comprehensive review of the neonatal Fc receptor and its application in drug delivery
  385. An In Situ Gelling Drug Delivery System for Improved Recovery after Spinal Cord Injury
  386. Neovascularization: Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound (Adv. Healthcare Mater. 8/2016)
  387. Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound
  388. Functionalized nanoparticles for targeting the gastrointestinal apical membrane receptors
  389. Mesoporous Biomaterials: a Lexicon and Structured Bibliography of Reviews
  390. Chemotherapy with Porous Silicon
  391. In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy
  392. Corrigendum to “Polymer-based nanoparticles for oral insulin delivery: Revisited approaches”,[Biotechnol Adv. 2015 Nov 1;33 (6 Pt 3):1342–54]
  393. Opinion Paper: Microfluidics Technique to Revolutionize the Drug Delivery Field: Current Developments and Applications
  394. Copolymers: Drug Delivery
  395. Controlled Shape and Nucleation Switching of Interfacially Polymerizable Nanoassemblies by Methyl Substitution
  396. Advanced Nanomedicines for the Treatment and Diagnosis of Myocardial Infarction and Heart Failure
  397. Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: A controlled dual protein-drug delivery system
  398. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches
  399. Cyclodextrin-Modified Porous Silicon Nanoparticles for Efficient Sustained Drug Delivery and Proliferation Inhibition of Breast Cancer Cells
  400. Smart Porous Silicon Nanoparticles with Polymeric Coatings for Sequential Combination Therapy
  401. Multimodal non-linear optical imaging for the investigation of drug nano-/microcrystal–cell interactions
  402. Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs
  403. Simple Microfluidic Approach to Fabricate Monodisperse Hollow Microparticles for Multidrug Delivery
  404. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation
  405. Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib
  406. Diatomite nanoparticles as potential drug delivery systems
  407. Inhibition of Multidrug Resistance of Cancer Cells by Co-Delivery of DNA Nanostructures and Drugs Using Porous Silicon Nanoparticles@Giant Liposomes
  408. Microfluidics: A Versatile and Robust Microfluidic Platform Toward High Throughput Synthesis of Homogeneous Nanoparticles with Tunable Properties (Adv. Mater. 14/2015)
  409. Multifunctional porous silicon nanoparticles for cancer theranostics
  410. Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy
  411. Drug Delivery: On-Chip Self-Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications (Adv. Funct. Mater. 10/2015)
  412. A Versatile and Robust Microfluidic Platform Toward High Throughput Synthesis of Homogeneous Nanoparticles with Tunable Properties
  413. Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration
  414. 3.5 Current Trends and Developments for Nanotechnology in Cancer
  415. On-Chip Self-Assembly of a Smart Hybrid Nanocomposite for Antitumoral Applications
  416. Functionalization of Alkyne-Terminated Thermally Hydrocarbonized Porous Silicon Nanoparticles With Targeting Peptides and Antifouling Polymers: Effect on the Human Plasma Protein Adsorption
  417. Mesoporous Biomaterials – multifunctional materials for future medical therapies and bioanalysis
  418. Surface bioengineering of diatomite based nanovectors for efficient intracellular uptake and drug delivery
  419. Microfluidic assisted one-step fabrication of porous silicon@acetalated dextran nanocomposites for precisely controlled combination chemotherapy
  420. Solid state transformations in consequence of electrospraying – A novel polymorphic form of piroxicam
  421. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers
  422. A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors
  423. Revolutionary impact of nanovaccines on immunotherapy
  424. Coherent anti-Stokes Raman scattering microscopy driving the future of loaded mesoporous silica imaging
  425. In vitro assessment of biopolymer-modified porous silicon microparticles for wound healing applications
  426. Surface chemistry dependent immunostimulative potential of porous silicon nanoplatforms
  427. The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium
  428. Antihyperglycemic Potential of Incretins Orally Delivered via Nano and Microsystems and Subsequent Glucoregulatory Effects
  429. Targeting Membrane Transporters and Receptors as a mean to Optimize Orally Delivered Biotechnological based Drugs through Nanoparticle Delivery Systems
  430. In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart
  431. Microfluidics-assisted engineering of polymeric microcapsules with high encapsulation efficiency for protein drug delivery
  432. Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering
  433. Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers
  434. In Vivo Evaluation of Porous Silicon and Porous Silicon Solid Lipid Nanocomposites for Passive Targeting and Imaging
  435. Gene-based therapy for Type 1 diabetes mellitus: viral and nonviral vectors
  436. Fabrication of a Multifunctional Nano-in-micro Drug Delivery Platform by Microfluidic Templated Encapsulation of Porous Silicon in Polymer Matrix
  437. Conjugation of Peptides to Antisense Interleukin-6 Via Click Chemistry
  438. Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications
  439. Microfluidic Assembly of Monodisperse Multistage pH-Responsive Polymer/Porous Silicon Composites for Precisely Controlled Multi-Drug Delivery
  440. Confinement Effects on Drugs in Thermally Hydrocarbonized Porous Silicon
  441. Poly(methyl vinyl ether-alt-maleic acid)-Functionalized Porous Silicon Nanoparticles for Enhanced Stability and Cellular Internalization
  442. Mesoporous Materials and Nanocrystals for Enhancing the Dissolution Behavior of Poorly Water-soluble Drugs
  443. Microfluidic assembly of multistage porous silicon–lipid vesicles for controlled drug release
  444. Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors
  445. Biocompatibility of porous silicon for biomedical applications
  446. Copper-free azide–alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake
  447. Preface
  448. Diatom silica microparticles for sustained release and permeation enhancement following oral delivery of prednisone and mesalamine
  449. Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy
  450. Microfluidic Templated Mesoporous Silicon–Solid Lipid Microcomposites for Sustained Drug Delivery
  451. The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility
  452. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles
  453. Inhibition of Influenza A Virus Infection in Vitro by Saliphenylhalamide-Loaded Porous Silicon Nanoparticles
  454. Drug delivery with nanostructured porous silicon nanoparticles
  455. Nanostructured Silicon-Based Materials as a Drug Delivery System for Water-Insoluble Drugs
  456. Metabolism of the Antituberculosis Drug Ethionamide
  457. Porous Silicon Nanoparticles
  458. Evaluation of the Physicochemical and Biopharmaceutical Properties of Fluoro-Indomethacin
  459. Editorial (Hot Topic: Non-Animal Models Used in Drug Discovery: Drug Absorption and Metabolism)
  460. Improving Oral Absorption Via Drug-Loaded Nanocarriers: Absorption Mechanisms, Intestinal Models and Rational Fabrication
  461. Encyclopedia of Metalloproteins
  462. Nanostructured Porous Silicon-Solid Lipid Nanocomposite: Towards Enhanced Cytocompatibility and Stability, Reduced Cellular Association, and Prolonged Drug Release
  463. Oral Delivery of Glucagon-like Peptide-1 and Analogs: Alternatives for Diabetes Control?
  464. A new cocrystal and salts of itraconazole: Comparison of solid-state properties, stability and dissolution behavior
  465. Nanostructured porous Si-based nanoparticles for targeted drug delivery
  466. Porous-based biomaterials for tissue engineering and drug delivery applications
  467. Amine Modification of Thermally Carbonized Porous Silicon with Silane Coupling Chemistry
  468. Toxicological Profile of Therapeutic Nanodelivery Systems
  469. Nanostructured porous silicon materials: potential candidates for improving drug delivery
  470. Nanostructured porous silicon in preclinical imaging: Moving from bench to bedside
  471. New times, new trends for ethionamide: In vitro evaluation of drug-loaded thermally carbonized porous silicon microparticles
  472. The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems
  473. Intravenous Delivery of Hydrophobin-Functionalized Porous Silicon Nanoparticles: Stability, Plasma Protein Adsorption and Biodistribution
  474. Nanoparticulate targeted drug delivery using peptides and proteins
  475. Cellular interactions of surface modified nanoporous silicon particles
  476. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles
  477. Functional hydrophobin-coating of thermally hydrocarbonized porous silicon microparticles
  478. 18F-Labeled Modified Porous Silicon Particles for Investigation of Drug Delivery Carrier Distribution in Vivo with Positron Emission Tomography
  479. Editorial [Hot Topic: Innovative Technologies for Drug Delivery Applications: From Biopolymers and Nanocapsules to Inorganic Materials (Guest Editor: Helder A. Santos)]
  480. Multifunctional Porous Silicon for Therapeutic Drug Delivery and Imaging
  481. 4th BBBB International Conference on Pharmaceutical Sciences
  482. Poster Presentation
  483. Drug Delivery Formulations of Ordered and Nonordered Mesoporous Silica: Comparison of Three Drug Loading Methods
  484. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole
  485. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles
  486. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles
  487. Mesoporous materials as controlled drug delivery formulations
  488. In vitro cytotoxicity of porous silicon microparticles: Effect of the particle concentration, surface chemistry and size
  489. Long time effect on the stability of silver nanoparticles in aqueous medium: Effect of the synthesis and storage conditions
  490. Biocompatibility of Thermally Hydrocarbonized Porous Silicon Nanoparticles and their Biodistribution in Rats
  491. Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells
  492. Electrochemical Properties of Phospholipid Monolayers at Liquid–Liquid Interfaces
  493. Biocompatibility of mesoporous silicon microparticles
  494. Drug dissolution studies on mesoporous silicon particles—A theoretical approach
  495. Failure of MTT as a Toxicity Testing Agent for Mesoporous Silicon Microparticles
  496. Thermodynamic analysis of binding between drugs and glycosaminoglycans by isothermal titration calorimetry and fluorescence spectroscopy
  497. Adsorption–Penetration Studies of Glucose Oxidase into Phospholipid Monolayers at the 1,2-Dichloroethane/Water Interface
  498. Cover Picture: Effect of Gramicidin on Phospholipid-Modified Monolayers and on Ion Transfer at a Liquid–Liquid Interface (ChemPhysChem 6/2007)
  499. Effect of Gramicidin on Phospholipid-Modified Monolayers and on Ion Transfer at a Liquid–Liquid Interface
  500. Analysis of adsorption of phospholipids at the 1,2-dichloroethane/water interface by electrochemical impedance spectroscopy: A study of the effect of the saturated alkyl chain
  501. Preparation of nanostructures composed of dextran sulfate/ruthenium nanoparticles and their interaction with phospholipid monolayers at a liquid–liquid interface
  502. Electrochemical Study of Interfacial Composite Nanostructures:  Polyelectrolyte/Gold Nanoparticle Multilayers Assembled on Phospholipid/Dextran Sulfate Monolayers at a Liquid−Liquid Interface
  503. Interfacial Interaction between Dextran Sulfate and Lipid Monolayers:  An Electrochemical Study†
  504. CHAPTER 9. Diatoms: A Natural Source of Nanostructured Silica for Drug Delivery